FDA inspection
PROVEPHARM Life Solutions: FDA inspection ending Apr 19, 2024
FDA inspection 1239790 · Official Action Indicated (OAI) · Marseille
Key facts
| Inspection ID | 1239790 |
|---|---|
| Firm | PROVEPHARM Life Solutions |
| FEI number | 3017911817 |
| Address | Rue Paul Langevin, 20 Rue Marc Donadille |
| City | Marseille |
| Fiscal year | 2024 |
| Inspection end date | Apr 19, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data